Know Cancer

or
forgot password

Pilot Study of a Multicenter, Telephone-Based Exercise Intervention for Patients With Early-Stage Breast and Colorectal Cancer: The Active After Cancer Trial (AACT)


N/A
18 Years
N/A
Open (Enrolling)
Both
Breast Cancer, Colorectal Cancer

Thank you

Trial Information

Pilot Study of a Multicenter, Telephone-Based Exercise Intervention for Patients With Early-Stage Breast and Colorectal Cancer: The Active After Cancer Trial (AACT)


Inclusion Criteria:



- Histologically confirmed stage I-III breast or colorectal cancer

- 18 years of age or older

- Completed adjuvant treatment(for current malignancy)

- Completion of all adjuvant chemotherapy and radiation (with the exception of adjuvant
herceptin and/or tamoxifen/aromatase inhibitor therapy for breast cancer patients)
between 2 and 36 months prior to enrollment

- Ability to speak and read English

- Willingness to be randomized

- Medical clearance from an oncologist or primary care physician stating the
participant is able to participate in an unsupervised, moderate-intensity physical
activity program

- No major surgery within 2 months of study enrollment or planned during study period

Exclusion Criteria:

- Metastatic cancer

- Uncontrolled intercurrent illness including, but not limited to, symptomatic
congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or
psychiatric illness that would limit compliance with study requirements

- Plans to have hip or knee replacement within a year

- Participation in more than 60 minutes a week of moderate-intensity recreational
activity as assessed by the International Physical Activity Questionnaire Short Form

- BMI >47

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

To evaluate the ability of a multi-center, telephone-based physical activity intervention to increase weekly physical activity levels in sedentary patients treated with adjuvant chemotherapy for Stage I-III breast or colorectal cancer.

Outcome Time Frame:

months

Safety Issue:

No

Principal Investigator

Jennifer Ligibel, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dana-Farber Cancer Institute

Authority:

United States: Institutional Review Board

Study ID:

07-266

NCT ID:

NCT00548236

Start Date:

October 2007

Completion Date:

September 2012

Related Keywords:

  • Breast Cancer
  • Colorectal Cancer
  • exercise intervention
  • AACT
  • Breast Neoplasms
  • Colorectal Neoplasms

Name

Location

Vermont Cancer CenterBurlington, Vermont  05401-3498
Dana-Farber Cancer InstituteBoston, Massachusetts  02115
Hematology Oncology Associates of Central New YorkSyracuse, New York  13217-6962
University of California San FranciscoSan Francisco, California  941104206
University of California at San DiegoLa Jolla, California  92093
Ohio State UniversityColumbus, Ohio  43210
New Hampshire Oncology HematologyConcord, New Hampshire  03106
Lakes Regional Healthcare Hematology OncologyHooksett, New Hampshire  03106
Rosewell Park Cancer InstituteBuffalo, New York  14263